Xgeva (denosumab, AMG 162; Human Monoclonal Antibody to RANK Ligand)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) March 2016 WARNINGS AND PRECAUTIONS Hypercalcemia Following Treatment Discontinuation in Patients with Growing Skeletons ...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts